Empowered Patient Podcast
1) New Gut-Brain Signaling Drug Targets Prader-Willi Syndrome with Dr. Tien Lee Aardvark Therapeutics TRANSCRIPT
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, draws a clear distinction between appetite and hunger and the implications for treating metabolic conditions and managing weight. The Aardvark l...Show More
2) New Gut-Brain Signaling Drug Targets Prader-Willi Syndrome with Dr. Tien Lee Aardvark Therapeutics
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, draws a clear distinction between appetite and hunger and the implications for treating metabolic conditions and managing weight. The Aardvark l...Show More
3) New Hepatitis B Oral Treatment Blocks Viral Integration and Progression with Lawrence Blatt Aligos Therapeutics TRANSCRIPT
Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics, describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease a...Show More
4) New Hepatitis B Oral Treatment Blocks Viral Integration and Progression with Lawrence Blatt Aligos Therapeutics
Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics, describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease a...Show More
5) Reality Check from Biotech Leaders on Using AI in Drug Discovery with BioXcel Therapeutics Gain Therapeutics iBio TRANSCRIPT
This roundtable on the role of AI in the biotech sector features Frank Yocca, Senior VP and Chief Scientific Officer at BioXcel Therapeutics, Joanne Taylor, Senior VP for Research at Gain Therapeutics...Show More
6) Reality Check from Biotech Leaders on Using AI in Drug Discovery with BioXcel Therapeutics Gain Therapeutics iBio
This roundtable on the role of AI in the biotech sector features Frank Yocca, Senior VP and Chief Scientific Officer at BioXcel Therapeutics, Joanne Taylor, Senior VP for Research at Gain Therapeutics...Show More
7) Developing Multi-Antigen Vaccines for Immunocompromised Patients with David Dodd GeoVax TRANSCRIPT
David Dodd, CEO of GeoVax, highlights the need for next-generation vaccines, specifically multi-antigen and T cell-focused technologies, to provide better protection for immunocompromised populations...Show More
8) Developing Multi-Antigen Vaccines for Immunocompromised Patients with David Dodd GeoVax
David Dodd, CEO of GeoVax, highlights the need for next-generation vaccines, specifically multi-antigen and T cell-focused technologies, to provide better protection for immunocompromised populations...Show More
9) Virtual Support Groups Remove Barriers Encourage Sharing Honest Experiences to Fight Misinformation with Rick Davis AnCan TRANSCRIPT
Rick Davis, patient advocate and Founder of AnCan, is building and operating virtual peer-to-peer support groups to allow patients to connect with others who have direct experience with their conditio...Show More
10) Virtual Support Groups Remove Barriers Encourage Sharing Honest Experiences to Fight Misinformation with Rick Davis AnCan
Rick Davis, patient advocate and Founder of AnCan, is building and operating virtual peer-to-peer support groups to allow patients to connect with others who have direct experience with their conditio...Show More